Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients

R.Duchnowska; J.Jassem; C.Szczylik; G.W.Sledge Jr.; L.Li; B.Czartoryska-Arlukowicz; B.Radecka; K.Sosinska; P.Steeg; S.Badve

首页> 外文期刊>European Journal of Cancer Supplements >Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients

【24h】

Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients

机译：通过基因表达分析预测HER2阳性转移性乳腺癌患者脑复发

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第7期|共1页
作者
R.Duchnowska; J.Jassem; C.Szczylik; G.W.Sledge Jr.; L.Li; B.Czartoryska-Arlukowicz; B.Radecka; K.Sosinska; P.Steeg; S.Badve;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients [J] . R.Duchnowska, J.Jassem, C.Szczylik, European Journal of Cancer Supplements . 2008,第7期

机译：通过基因表达分析预测HER2阳性转移性乳腺癌患者脑复发
2. Risk factors for brain relapse in HER2-positive metastatic breast cancer patients. [J] . Duchnowska R, Dziadziuszko R, Czartoryska Arlukowicz B, Breast cancer research and treatment. . 2009,第2期

机译：HER2阳性转移性乳腺癌患者脑复发的危险因素。
3. Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab [J] . Peter Grell, Pavel Fabian, Marta Khoylou, International journal of oncology . 2012,第4期

机译：曲妥珠单抗治疗HER2阳性转移性乳腺癌患者Akt表达和区隔预测临床结局
4. Prediction Models for Estimation of Survival Rate and Relapse for Breast Cancer Patients [C] . Bojana R. Andjelkovic Cirkovic, Aleksandar M. Cvetkovic, Srdjan M. Ninkovic, IEEE International Conference on Bioinformatics and Bioengineering . 2015

机译：乳腺癌患者存活率和复发估算预测模型
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab [O] . PETER GRELL, PAVEL FABIAN, MARTA KHOYLOU, -1

机译：曲妥珠单抗治疗HER2阳性转移性乳腺癌患者Akt表达和区隔预测临床结局
7. Risk factors for brain relapse in HER2-positive metastatic breast cancer patients [O] . Duchnowska, Renata, Dziadziuszko, Rafał, Czartoryska-Arłukowicz, Bogumiła, 2009

机译：HER2阳性转移性乳腺癌患者脑复发的危险因素

Prediction of brain relapse by gene expression analysis in HER2-positive metastatic breast cancer patients

著录项

相似文献

相关主题

期刊订阅